Holden Thorp is Rita Levi-Montalcini Distinguished University Professor and holds appointments in both chemistry and medicine. He was provost and executive vice chancellor for academic affairs at Washington University in St. Louis from July 1, 2013 to July 15, 2019.
On October 28, Thorp will become Editor-in-Chief of the Science family of journals. The journal Science has the largest paid circulation of any peer-reviewed, general science journal in the world. The Science family of journals includes Science, Science Translational Medicine, Science Signaling, Science Robotics, Science Immunology, and the open-access journal, Science Advances. Thorp will continue to serve on the WashU faculty and will be on leave while serving as Editor-in-Chief.
Thorp joined the university after spending three decades at the University of North Carolina at Chapel Hill where he served as the 10th chancellor from 2008 through 2013.
A North Carolina native, Thorp started at UNC as an undergraduate student and earned a bachelor of science degree in chemistry with highest honors in 1986. He earned a doctorate in chemistry in 1989 at the California Institute of Technology and completed post-doctoral work at Yale University. He holds an honorary Doctor of Laws from North Carolina Wesleyan College and is a Fellow of the National Academy of Inventors.
In his research career, Thorp developed technology for electronic DNA chips and co-founded Viamet Pharmaceuticals and Innocrin Pharmaceuticals, which are commercializing new drugs for fungal disease and prostate cancer, respectively. Thorp is a venture partner at Hatteras Venture Partners and on the board of directors of the College Advising Corps and Artizan Biosciences.
On higher education, music and entrepreneurship in the Heartland